Erwan Bezard

Affiliations: 
Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 
Area:
neurodegenerative disorders
Website:
http://www.inb.u-bordeaux2.fr/dev/FR/equipe.php?equipe=Physiopathologie%20des%20syndromes%20parkinsoniens
Google:
"Erwan Bezard"
Bio:

Bezard has authored or co-authored over 90 professional publications in the field of neurobiology, most of which are on Parkinson's disease and related disorders. He is perhaps best known for the reappraisal of both the identification of the nature of compensatory mechanisms that mask the progression Parkinson's disease and their sequential activation in non-human primate models that mimic Parkinson’s progression. His current research interests include the study of the compensatory mechanisms, the levodopa-induced dyskinesia, the basic pathophysiology of basal ganglia circuitry, and the development of new strategies to alleviate symptoms and/or to slow disease progression.

He has recently been appointed as a Visiting Professor at the China Academy of Medical Sciences (Beijing, China) where he has set-up and manages a non-human primate facility dedicated to Movement Disorders. He serves on the board of international organizations such as the International Basal Ganglia Society and the Michael J. Fox Foundation. He is Associate Editor of Neurobiology of Disease and he serves on the editorial boards of several neurobiology journals. Besides consulting for several drug companies in the field of movement disorders, he is a non-executive director of Plenitudes Sarl (France), Motac Neuroscience (UK) and Motac Cognition (USA).

(Show less)

Mean distance: 15.8 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cirillo R, Duperrier S, Parekh P, et al. (2024) Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia. Journal of Parkinson's Disease
Darricau M, Dou C, Kinet R, et al. (2023) Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Teil M, Dovero S, Bourdenx M, et al. (2023) Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain. Npj Parkinson's Disease. 9: 135
Serra M, Di Maio A, Bassareo V, et al. (2023) Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 106226
Lopez-Cuina M, Guérin P, Dutheil N, et al. (2023) GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society
Darricau M, Katsinelos T, Raschella F, et al. (2022) Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates. Brain : a Journal of Neurology
Teil M, Doudnikoff E, Thiolat ML, et al. (2022) The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced Neurodegeneration. Molecular Neurobiology
Arotcarena ML, Soria FN, Cunha A, et al. (2022) Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function. Aging Cell. 21: e13584
Teil M, Dovero S, Bourdenx M, et al. (2022) Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. Brain : a Journal of Neurology
Bezard E, Dehay B. (2022) [Aggregation and spread of synuclein in Parkinson's disease]. Medecine Sciences : M/S. 38: 45-51
See more...